nach oben

International Journal of Clinical Oncology

Erschienen in:

25.05.2016 | Original Article

Association of atopic diseases and parvovirus B19 with acute lymphoblastic leukemia in childhood and adolescence in the northeast of Brazil

verfasst von: Joacilda da Conceição Nunes, Georgia Véras de Araujo, Marcelo Tavares Viana, Emanuel Sávio Cavalcanti Sarinho

Erschienen in: International Journal of Clinical Oncology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Several factors related to the immune system, such as a history of allergies and virus infections, may be associated with acute lymphoblastic leukemia (ALL). The purpose of this study was to analyze whether the presence of atopic diseases and previous infection with parvovirus B19 and Epstein−Barr virus (EBV) are associated with the development of ALL.

Methods

This case–control study was performed in two tertiary hospitals located in northeastern Brazil. The study population included 60 patients who were diagnosed with non-T-cell ALL using myelogram and immunophenotyping and 120 patients in the control group. Atopy was evaluated via a parent questionnaire and medical records. Total immunoglobulin (Ig)E and IgG levels of parvovirus B19 and EBV were measured in the serum. Logistic regression was performed to assess the association between variables and odds of ALL.

Results

We identified a significant inverse association between rhinitis, urticaria and elevated IgE serum levels with ALL. A history of parvovirus B19 infection showed a significant association with this type of cancer [OR (95 % CI) 2.00 (1.94–4.26); P = 0.050]. In logistic regression, the presence of atopy was a protective factor [OR (95 % CI) 0.57 (0.38–0.83); P = 0.004], and the presence of IgG for parvovirus B19 was an important risk factor for ALL [OR (95 % CI) 2.20 (1.02–4.76); P = 0.043].

Conclusions

These results suggest that atopic diseases and elevated total IgE levels are associated with a potential protective effect on the development of ALL. Previous infection with parvovirus B19 contributed to ALL susceptibility.

Stiller CA (2004) Epidemiology and genetics of childhood cancer. Oncogene 3:6429–6444CrossRef

Stewart A, Webb J, Hewitt D (1958) A survey of childhood malignancies. Br Med J 1:1495–1508CrossRefPubMedPubMedCentral

Dahl G, Wiemels J (2015) What causes leukemia? Pediatr Blood Cancer 62:1123–1124CrossRefPubMed

Greaves MF (1988) Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 2:120–125PubMed

Greaves M (2006) Infection, immune responses and the etiology of childhood leukemia. Nat Rev Cancer 6:193–203CrossRefPubMed

Kinlen L (1988) Evidence for an infective cause of childhood leukemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet 2:1323–1327CrossRefPubMed

Smith M (1997) Considerations on a possible viral etiology for B-precursor acute lymphoblastic leukemia of childhood. J Immunother 20:89–100CrossRefPubMed

Ries LAG, Smith MA, Gurney JG et al (1999). Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. NIH publication no. 99-4649. National Cancer Institute, Bethesda. http://seer.cancer.gov/archive/publications/childhood/childhood-monograph.pdf. Accessed 5 Jan 2014

Turner MC, Chen Y, Krewski D et al (2006) An overview of the association between allergy and cancer. Int J Cancer 118:3124–3132CrossRefPubMed

10.

Linabery AM, Spector LG (2012) Invited commentary: childhood acute lymphoblastic and allergies: biology or bias? Am J Epidemiol 76:979–983CrossRef

11.

Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen cellular receptor for parvovirus B19. Science 262:114–117CrossRefPubMed

12.

GINA (Global Initiative for Asthma), National Heart, Lung, and Blood Institute (NHLBI) (2006). Global strategy for asthma management and prevention. GINA, Bethesda, p 339. http://www.ginasthma.org. Accessed 10 Feb 2014

13.

Demoly P, Allaert FA, Lecasble M et al (2003) PRAGMA validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 58:672–675CrossRefPubMed

14.

Kunz B, Oranje AP, Labrèze L et al (1997) Clinical validation and guidelines for the SCORAD Index: consensus report of the European Task Force on atopic dermatitis. Dermatology 195:10–19CrossRefPubMed

15.

Zuberbier T, Asero R, Bindslev-Jensen C et al (2009) EAACI/GA2 LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 64:1417–1426CrossRefPubMed

16.

Grattan C, Powell S, Humphreys F (2001) Management and diagnostic guidelines for urticaria and angio-edema. Br J Dermatol 144:708–714CrossRefPubMed

17.

Zuberbier T, Asero R, Bindslev-Jensen C et al (2009) EAACI/GA2 LEN/EDF/WAO guideline: management of urticaria. Allergy 64:1427–1443CrossRefPubMed

18.

Hughes AM, Lightfoot T, Simpson J et al (2007) Allergy and risk of childhood leukaemia: results from the UKCCS. Int J Cancer 121:819–824CrossRefPubMed

19.

Linet MS, McCaffrey LD, Humphrey RL et al (1986) Chronic lymphocytic leukemia and acquired disorders affecting the immune system: a case-control study. J Natl Cancer Inst 77:371–378PubMed

20.

Linabery AM, Jurek AM, Duval S et al (2010) The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol 171:749–764CrossRefPubMedPubMedCentral

21.

Chang JS, Tsai Y, Tsai C et al (2012) Allergy and risk of childhood acute lymphoblastic leukemia: a population-based and record-based. Am J Epidemiol 76:970–978CrossRef

22.

Markiewicz MA, Gajewski TF (1999) The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response. Crit Rev Oncog 10:247–260PubMed

23.

Kersey JH, Shapiro RS, Filipovich AH (1988) Relationship of immunodeficiency to lymphoid malignancy. Pediatric Infect Dis J 7:10–12CrossRef

24.

Ellyard JI, Simpson L, Parish CR (2007) Th2-mediated anti-tumor immunity: friend or foe? Tissue Antigens 70:1–11CrossRefPubMed

25.

Kinlen LJ, Balkwill A (2001) Infective cause of childhood leukaemia and wartime population mixing in Orkney and Shetland, UK. Lancet 357:858CrossRefPubMed

26.

Fernandez AF, Esteller M (2010) Viral epigenomes in human tumorigenesis. Oncogene 29:1405–1420CrossRefPubMed

27.

Jitschin R, Peters O, Plentz A et al (2011) Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders. Clin Microbiol Infect 17:1336–1342CrossRefPubMed

28.

Wiemels J, Kang M, Greaves M (2009) Backtracking of leukemic clones to birth. Methods Mol Biol 538:7–27CrossRefPubMed

Titel: Association of atopic diseases and parvovirus B19 with acute lymphoblastic leukemia in childhood and adolescence in the northeast of Brazil
verfasst von: Joacilda da Conceição Nunes
Georgia Véras de Araujo
Marcelo Tavares Viana
Emanuel Sávio Cavalcanti Sarinho
Publikationsdatum: 25.05.2016
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 5/2016
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-016-0988-7

Springer Medizin

Association of atopic diseases and parvovirus B19 with acute lymphoblastic leukemia in childhood and adolescence in the northeast of Brazil